At Ashfield MedComms, I own financial oversight for approximately $12M of client work across 6–8 pharmaceutical clients. I partner with account teams on project budgets, pricing and SOW accuracy, billing, contracting, and month-end revenue outlooks.
I coordinate monthly revenue-recognition and forecast reviews, challenging assumptions and investigating variances. In 2026, I identified approximately $400K of year-end revenue at risk on one account and challenged high forecast assumptions on another, contributing to projected net revenue reductions by October.
I also identified approximately $500K in revenue blocked by missing purchase orders and followed up through resolution, when the work was billed and cash collected. Earlier, at IP Brands LLC, I supported financial and operational decisions through financial-statement analysis, cash-flow forecasting, reconciliations, and financial modeling.
